首过效应,指某些药物经胃肠道给药,在尚未吸收进入血循环之前,在肠粘膜和肝脏被代谢,而使进入血循环的原形药量减少的现象,也称第一关卡效应。某些药物口服后在通过肠粘膜及肝脏而经受灭活代谢后,进入体循环的药量减少、药效降低效应。因给药途径不同而使药物效应产生差别的现象在治疗学上有重要意义。
目的:探讨小肠在首过效应中的作用。
Objective: To explore the first-pass effect in Small intestine.
结论DBDCT在大鼠肝微粒体中代谢较快,提示该药可能肝首过效应较强。
ConclusionThe metabolism of DBDCT in rat liver microsomes was faster, suggesting that the liver first-pass effect of the drug may be stronger.
文献表明槲皮素生物活性低是由于其低的生物利用度,溶解性差与首过效应是影响其生物利用度的主要因素。
Documents show that the low biological activity of quercetin is due to its low bioavailability. Poor solubility and first-pass effect are the main factors that affect its bioavailability.
应用推荐